Announcement on the 2025 Follow-up Rating Result of Convertible Corporate Bonds

About this update from Dashenlin Pharmaceutical Group Co., Ltd. Class A

Announcement on the 2025 Follow-up Rating Result of Convertible Corporate BondsThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Dashenlin Pharmaceutical Group Co., Ltd. Class A